azacitidine has been researched along with Rhabdomyosarcoma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Baumgart, JT; Helman, LJ; Juarez, JOM; McCalla, A; Slemmons, KK; Yeung, C | 1 |
| Czerewaty, M; Grymuła, K; Poniewierska-Baran, A; Ratajczak, MZ; Tarnowski, M; Tkacz, M | 1 |
| Cuvelier, N; Fernandez-Zapico, ME; Frommhold, A; Hahn, H; Johnsen, SA; Nitzki, F; Salinas-Riester, G; Tolosa, EJ | 1 |
| Bisogno, G; Celegato, B; Lanfranchi, G; Martini, P; Millino, C; Pacchioni, B; Poli, E; Romualdi, C; Rosolen, A; Tombolan, L; Zin, A | 1 |
| Dullin, C; Ecke, I; Hahn, H; Hess, I; Johnsen, SA; Kimmina, S; Mönkemeyer, S; Nitzki, F; Petry, F; Pirngruber, J; Rosenberger, A; Schulz-Schaeffer, W; Tauber, S; Uhmann, A; Witt, O; Wojnowski, L | 1 |
| Abraham, J; Davie, J; Keller, C; Londhe, P; Zhu, B | 1 |
| Bestor, TH; Lynch, CA; Tycko, B; Walsh, CP | 1 |
| Asa, SL; Ezzat, S; Ladanyi, M; Yu, SJ; Zheng, L | 1 |
| Boon, T; De Plaen, E; De Smet, C; Naerhuyzen, B; Szikora, JP | 1 |
| Chen, B; He, L; Jenkins, JJ; Parham, DM; Savell, VH | 1 |
| Elliott, MS; Gündüz, U; Houghton, JA; Houghton, PJ; Katze, JR; Seubert, PH; Trewyn, RW | 1 |
| De Giovanni, C; Del Re, B; Landuzzi, L; Lollini, PL; Nanni, P; Nicoletti, G; Prodi, G; Scotlandi, K | 1 |
12 other study(ies) available for azacitidine and Rhabdomyosarcoma
| Article | Year |
|---|---|
Targeting Hippo-Dependent and Hippo-Independent YAP1 Signaling for the Treatment of Childhood Rhabdomyosarcoma.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents; Apoptosis; Azacitidine; Cell Proliferation; Child; Female; Gene Expression Regulation, Neoplastic; Hippo Signaling Pathway; Humans; Mice; Mice, SCID; Molecular Targeted Therapy; Protein Serine-Threonine Kinases; Rhabdomyosarcoma; Signal Transduction; Transcription Factors; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; YAP-Signaling Proteins | 2020 |
5‑Azacytidine inhibits human rhabdomyosarcoma cell growth by downregulating insulin‑like growth factor 2 expression and reactivating the H19 gene product miR‑675, which negatively affects insulin‑like growth factors and insulin signaling.
Topics: Antineoplastic Agents; Apoptosis; Azacitidine; Blotting, Western; Cell Line, Tumor; Cell Proliferation; DNA Methylation; Down-Regulation; Flow Cytometry; Gene Expression Regulation, Neoplastic; Genomic Imprinting; Humans; Insulin; Insulin-Like Growth Factor II; MicroRNAs; Receptor, Insulin; Reverse Transcriptase Polymerase Chain Reaction; Rhabdomyosarcoma; RNA, Long Noncoding; Signal Transduction; Transfection | 2015 |
Overexpression of mutant Ptch in rhabdomyosarcomas is associated with promoter hypomethylation and increased Gli1 and H3K4me3 occupancy.
Topics: Animals; Azacitidine; CpG Islands; Decitabine; DNA Methylation; Embryonic Development; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Gestational Age; Heterozygote; Histones; Kruppel-Like Transcription Factors; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Models, Genetic; Mutation; Neoplasm Proteins; Patched Receptors; Patched-1 Receptor; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Protein Processing, Post-Translational; Receptors, Cell Surface; Rhabdomyosarcoma; Signal Transduction; Zinc Finger Protein GLI1 | 2015 |
Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma.
Topics: Azacitidine; Biopsy; Cell Adhesion Molecules, Neuronal; Cell Line, Tumor; Cluster Analysis; Cytidine Triphosphate; DNA Methylation; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genome-Wide Association Study; Humans; Hydroxamic Acids; Neoplasm Metastasis; Neuropeptides; Promoter Regions, Genetic; Protocadherins; Receptors, Cell Surface; Rhabdomyosarcoma; Transcriptome | 2016 |
Antitumor effects of a combined 5-aza-2'deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice.
Topics: Acetylation; Animals; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Gene Expression; Gene Silencing; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Medulloblastoma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Muscle, Skeletal; Patched Receptors; Patched-1 Receptor; Receptors, Cell Surface; Rhabdomyosarcoma; Valproic Acid | 2009 |
CIITA is silenced by epigenetic mechanisms that prevent the recruitment of transactivating factors in rhabdomyosarcoma cells.
Topics: Acetylation; Azacitidine; Cell Line, Tumor; Chromatin Immunoprecipitation; Decitabine; Epigenesis, Genetic; Flow Cytometry; Gene Expression Profiling; Gene Silencing; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Interferon-gamma; Nuclear Proteins; Promoter Regions, Genetic; Rhabdomyosarcoma; Signal Transduction; Trans-Activators | 2012 |
Reactivation of a silenced H19 gene in human rhabdomyosarcoma by demethylation of DNA but not by histone hyperacetylation.
Topics: Acetylation; Animals; Azacitidine; Blotting, Northern; Blotting, Western; Cell Line, Tumor; Cells, Cultured; DNA Methylation; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Insulin-Like Growth Factor II; Kidney; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pregnancy; Rhabdomyosarcoma; RNA; RNA, Long Noncoding; RNA, Untranslated; Tissue Plasminogen Activator | 2002 |
Sp1-mediated transcriptional control of fibroblast growth factor receptor 4 in sarcomas of skeletal muscle lineage.
Topics: Azacitidine; Base Sequence; Binding Sites; Blotting, Western; Cell Line, Tumor; DNA-Binding Proteins; Electrophoretic Mobility Shift Assay; Gene Expression Regulation, Neoplastic; Humans; Luciferases; Plasmids; Promoter Regions, Genetic; Receptor, Fibroblast Growth Factor, Type 4; Receptors, Fibroblast Growth Factor; Recombinant Fusion Proteins; Rhabdomyosarcoma; Sp1 Transcription Factor; Sp3 Transcription Factor; Transcription Factors; Transfection | 2004 |
Alternative promoters of gene MAGE4a.
Topics: Alternative Splicing; Amino Acid Sequence; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Azacitidine; Base Sequence; Cloning, Molecular; Decitabine; DNA-Binding Proteins; DNA, Neoplasm; Exons; Gene Expression Regulation, Neoplastic; Humans; Male; Melanoma; Molecular Sequence Data; Neoplasm Proteins; Placenta; Promoter Regions, Genetic; Restriction Mapping; Rhabdomyosarcoma; RNA, Messenger; Sequence Analysis, DNA; Testis; Tumor Cells, Cultured | 1997 |
Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Blotting, Southern; Cell Division; CpG Islands; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Decitabine; DNA Methylation; DNA Mutational Analysis; DNA-Binding Proteins; Dose-Response Relationship, Drug; Genes, Reporter; Humans; Interferon-gamma; Luciferases; Muscle Neoplasms; Muscle, Skeletal; Polymorphism, Genetic; Promoter Regions, Genetic; Response Elements; Rhabdomyosarcoma; Signal Transduction; STAT1 Transcription Factor; Time Factors; Trans-Activators; Transfection; Tumor Cells, Cultured; Up-Regulation | 2000 |
Absence of tRNA-guanine transglycosylase in a human colon adenocarcinoma cell line.
Topics: Adenocarcinoma; Animals; Azacitidine; Cell Cycle; Colonic Neoplasms; Guanine; Humans; Mice; Mutation; Neoplasm Transplantation; Pentosyltransferases; Rhabdomyosarcoma; RNA Processing, Post-Transcriptional; RNA, Transfer; Tumor Cells, Cultured | 1992 |
Myogenic differentiation of human rhabdomyosarcoma cells induced in vitro by antineoplastic drugs.
Topics: Antineoplastic Agents; Azacitidine; Cell Differentiation; Cell Division; Cell Fusion; Cisplatin; Cyclophosphamide; Cytarabine; Humans; In Vitro Techniques; Muscles; Myosins; Rhabdomyosarcoma; Tumor Cells, Cultured | 1989 |